OYSTER POINT PHARMA INC (OYST) Stock Balance Sheet
NASDAQ:OYST • US69242L1061
11.17 USD
+0.02 (+0.18%)
At close: Dec 30, 2022
11.17 USD
0 (0%)
After Hours: 12/30/2022, 8:00:02 PM
| MRQ (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | 5.20M | |||
| Cash Equivalents | 68.80M | 193.37M | 192.60M | 139.10M | N/A | |||
| Receivables | 13.18M | 6.66M | N/A | N/A | N/A | |||
| Inventories | 6.96M | 6.09M | N/A | N/A | N/A | |||
| Other Current Assets | 8.76M | 9.14M | 3.80M | 3.00M | 400.00K | |||
| Total Current Assets | 97.71M | 215.25M | 196.40M | 142.20M | 5.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.92M | 5.40M | 1.50M | 1.00M | 100.00K | |||
| Investments And Advances | 886.00K | 886.00K | N/A | N/A | N/A | |||
| Other Non-Current Assets | 5.69M | 1.08M | 100.00K | 100.00K | 0.00 | |||
| Total Non-Current Assets | 11.49M | 7.37M | 1.50M | 1.00M | 100.00K | |||
| TOTAL ASSETS | 109.20M | 222.62M | 197.90M | 143.20M | 5.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 17.00K | 16.00K | 0.00 | N/A | N/A | |||
| Accrued Expenses | 25.04M | 22.29M | 8.70M | 4.90M | 500.00K | |||
| Accounts Payable | 4.14M | 6.50M | 2.30M | 500.00K | 500.00K | |||
| Total Current Liabilities | 29.20M | 28.80M | 11.00M | 5.40M | 900.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 92.24M | 89.82M | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 9.97M | 4.46M | 300.00K | 500.00K | 0.00 | |||
| Total Non-Current Liabilities | 102.21M | 94.28M | 300.00K | 500.00K | 0.00 | |||
| TOTAL LIABILITIES | 131.40M | 123.08M | 11.30M | 5.90M | 900.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -389.99M | -255.41M | -154.80M | -84.20M | -38.50M | |||
| Additional Paid In Capital | 367.76M | 354.92M | 341.40M | 221.50M | 300.00K | |||
| Common Shares | 27.00K | 27.00K | 0.00 | 0.00 | 43.00M | |||
| Shares Outstanding | 26.83M | 26.58M | 25.90M | 21.40M | 20.60M | |||
| Tangible Book Value per Share | -0.83 | 3.74 | 7.21 | 6.42 | -1.85 | |||
| Total Shareholders' Equity | -22.20M | 99.54M | 186.70M | 137.30M | 4.80M | |||
| TOTAL LIABILITIES AND EQUITY | 109.20M | 222.62M | 197.90M | 143.20M | 5.70M | |||
| Statistics | ||||||||
| Debt/Equity | -4.15 | 0.90 | N/A | N/A | N/A | |||
| Current Ratio | 3.35 | 7.47 | 17.85 | 26.33 | 6.22 | |||
| Return On Assets (ROA) | -161.76% | -45.22% | -35.63% | -31.92% | -289.47% | |||
| Return On Equity (ROE) | N/A | -101.13% | -37.77% | -33.29% | -343.75% | |||
All data in USD , ROIC based on taxRate of 0.21